Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$147.24

-1.61 (-1.08%)

12:46
01/11/17
01/11
12:46
01/11/17
12:46

TESARO call volume above normal and directionally bullish

Bullish option flow detected in TESARO with 1,264 calls trading, 1.8x expected, and implied vol increasing almost 2 points to 54.80%. Jan-17 155 calls and Jan-18 110 puts are the most active options, with total volume in those strikes near 540 contracts. The Put/Call Ratio is 0.51. Earnings are expected on February 23rd.

  • 11

    Jan

  • 30

    Jun

TSRO Tesaro
$147.24

-1.61 (-1.08%)

12/27/16
FBRC
12/27/16
NO CHANGE
Target $151
FBRC
Outperform
FBR Capital ups TESARO price target to $151
FBR Capital analyst Ed White raised his price target for TESARO to $151 from $133 and keeps the Outperform rating on the shares. The oncology-focused biopharmaceutical company closed Friday up $7.27 to $139.86. TESARO recently announced that the FDA has granted Priority Review for niraparib with a June 30, 2017 action date, White tells investors in a research note. He believes niraparib could be a potential blockbuster PARP inhibitor. Meanwhile, the launch of Varubi continues to "ramp up," with sequential quarter-over-quarter unit growth of 14%, the analyst writes. White says the drug achieved a 28% share of the oral NK-1 market in the U.S. in September.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/09/17
LEER
01/09/17
NO CHANGE
Target $152
LEER
Outperform
TESARO price target raised to $152 from $115 at Leerink
Leerink analyst Seamus Fernandez raised his price target for TESARO to $152 from $115 to fully incorporate his high expectations for a broad label and reflect niraparib's transformation to a commercial stage asset. The analyst notes that the "strong data" from niraparib's NOVA trial, along with the lack of an expected FDA panel, should result in a broad label in the second-line or greater ovarian cancer maintenance setting, while ongoing niraparib trials in breast cancer and front-line ovarian cancer maintenance and the company's IO platform should be additional potential drivers of upside for the stock. Fernandez sees TESARO as an "attractive takeout target," and reiterates an Outperform rating on the shares.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.

TODAY'S FREE FLY STORIES

RHHBY

Roche

$32.60

0.18 (0.56%)

14:21
06/22/17
06/22
14:21
06/22/17
14:21
Hot Stocks
Roche reports FDA approval of Rituxan Hycela »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 13

    Jul

$NSD

NASDAQ Market Internals

14:17
06/22/17
06/22
14:17
06/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
06/22/17
06/22
14:16
06/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVG

Navigators

$52.80

-0.4 (-0.75%)

14:15
06/22/17
06/22
14:15
06/22/17
14:15
Initiation
Navigators initiated  »

Navigators initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

WDR

Waddell & Reed

$19.55

0.73 (3.88%)

, IVZ

Invesco

$35.07

0.27 (0.78%)

14:14
06/22/17
06/22
14:14
06/22/17
14:14
Recommendations
Waddell & Reed, Invesco, T. Rowe Price analyst commentary  »

Waddell & Reed…

WDR

Waddell & Reed

$19.55

0.73 (3.88%)

IVZ

Invesco

$35.07

0.27 (0.78%)

TROW

T. Rowe Price

$73.04

-0.3 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

RAD

Rite Aid

$3.15

-0.0443 (-1.39%)

, WBA

Walgreens Boots Alliance

$78.12

-0.18 (-0.23%)

14:13
06/22/17
06/22
14:13
06/22/17
14:13
Periodicals
Capitol Forum says Lipsky reccomends blocking Rite Aid deal, Bloomberg says »

The FTC is said to be set…

RAD

Rite Aid

$3.15

-0.0443 (-1.39%)

WBA

Walgreens Boots Alliance

$78.12

-0.18 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

MDRX

Allscripts

$12.19

0.11 (0.91%)

14:10
06/22/17
06/22
14:10
06/22/17
14:10
Options
Allscripts attracts bullish option flow as shares see strength »

Allscripts attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$6.43

-0.37 (-5.44%)

14:05
06/22/17
06/22
14:05
06/22/17
14:05
Options
Sears call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNK

Cinemark

$38.39

-1.43 (-3.59%)

, RGC

Regal Entertainment

$20.46

-0.3 (-1.45%)

14:02
06/22/17
06/22
14:02
06/22/17
14:02
Hot Stocks
Analyst says sell Cinemark on weaker theater outlook, VOD threat »

Credit Suisse downgraded…

CNK

Cinemark

$38.39

-1.43 (-3.59%)

RGC

Regal Entertainment

$20.46

-0.3 (-1.45%)

AMC

AMC Entertainment

$22.70

-0.35 (-1.52%)

IMAX

IMAX

$23.40

-0.8 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$228.17

1.08 (0.48%)

14:01
06/22/17
06/22
14:01
06/22/17
14:01
Hot Stocks
Martin Marietta announces Lloyd to retire as CFO »

Martin Marietta Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

AAL

American Airlines

$48.43

0.4 (0.83%)

13:59
06/22/17
06/22
13:59
06/22/17
13:59
Periodicals
American Air CEO: Not particularly excited about Qatar overture, Bloomberg says »

According to a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 07

    Jul

HMC

Honda

$27.57

0.004 (0.01%)

, NSANY

Nissan

$19.09

-0.02 (-0.10%)

13:55
06/22/17
06/22
13:55
06/22/17
13:55
Periodicals
Honda, Nissan, Toyota to support Takata through recovery, Nikkei reports »

Japanese auto giants…

HMC

Honda

$27.57

0.004 (0.01%)

NSANY

Nissan

$19.09

-0.02 (-0.10%)

TM

Toyota

$105.48

0.92 (0.88%)

TKTDY

Takata

$2.25

0.45 (25.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

SNCR

Synchronoss

$10.65

0.47 (4.62%)

, T

AT&T

$38.22

0.065 (0.17%)

13:53
06/22/17
06/22
13:53
06/22/17
13:53
Recommendations
Synchronoss, AT&T, Verizon analyst commentary  »

Synchronoss comments on…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

T

AT&T

$38.22

0.065 (0.17%)

VZ

Verizon

$45.54

0.125 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jul

DIS

Disney

$104.39

-0.41 (-0.39%)

13:49
06/22/17
06/22
13:49
06/22/17
13:49
Hot Stocks
Ron Howard takes over director duties on 'Han Solo' film »

Lucasfilm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SPWR

SunPower

$7.68

0.17 (2.26%)

, FSLR

First Solar

$37.23

1.78 (5.02%)

13:47
06/22/17
06/22
13:47
06/22/17
13:47
Hot Stocks
Solar stocks surge after Trump floats idea of sun-powered border wall »

Solar stocks soared…

SPWR

SunPower

$7.68

0.17 (2.26%)

FSLR

First Solar

$37.23

1.78 (5.02%)

JKS

JinkoSolar

$20.55

1.15 (5.93%)

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

JASO

JA Solar

$6.41

0.14 (2.23%)

TSLA

Tesla

$376.40

4.16 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

  • 02

    Oct

AZN

AstraZeneca

$35.50

0.62 (1.78%)

13:45
06/22/17
06/22
13:45
06/22/17
13:45
Options
AstraZeneca call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

PCRFY

Panasonic

$13.65

0.123 (0.91%)

13:37
06/22/17
06/22
13:37
06/22/17
13:37
Periodicals
Panasonic aims to double cumulative dishwasher sales by 2026, Nikkei says »

Panasonic said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
06/22/17
06/22
13:35
06/22/17
13:35
General news
NY Fed accepted $195.14 B in daily reverse repos »

NY Fed accepted $195.14 B…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

, VZ

Verizon

$45.52

0.11 (0.24%)

13:30
06/22/17
06/22
13:30
06/22/17
13:30
Earnings
Synchronoss sees 'negligible' 2017 revenue impact from AT&T 'Locker' shut down »

In a business update…

SNCR

Synchronoss

$10.65

0.47 (4.62%)

VZ

Verizon

$45.52

0.11 (0.24%)

T

AT&T

$38.22

0.07 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jul

PPC

Pilgrim's Pride

$23.33

-0.07 (-0.30%)

13:30
06/22/17
06/22
13:30
06/22/17
13:30
Options
Meaty put activity in Pilgrims Pride »

Meaty put activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$243.51

0.56 (0.23%)

, SPX

S&P 500

13:25
06/22/17
06/22
13:25
06/22/17
13:25
Technical Analysis
Technical View: S&P 500 in small very short-term bullish price channel »

Heading into afternoon…

SPY

SPDR S&P 500 ETF Trust

$243.51

0.56 (0.23%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTIC

CTI BioPharma

13:24
06/22/17
06/22
13:24
06/22/17
13:24
Hot Stocks
Breaking Hot Stocks news story on CTI BioPharma »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$10.65

0.47 (4.62%)

13:21
06/22/17
06/22
13:21
06/22/17
13:21
Earnings
Synchronoss says new FY17 guidance cannot be provided until review complete »

In slides that were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBRY

BlackBerry

$10.65

-0.08 (-0.75%)

, FINL

Finish Line

$12.50

-0.52 (-3.99%)

13:21
06/22/17
06/22
13:21
06/22/17
13:21
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BBRY

BlackBerry

$10.65

-0.08 (-0.75%)

FINL

Finish Line

$12.50

-0.52 (-3.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

BBBY

Bed Bath & Beyond

$33.66

-0.48 (-1.41%)

, INO

Inovio

$8.06

0.09 (1.13%)

13:20
06/22/17
06/22
13:20
06/22/17
13:20
Earnings
Notable companies reporting after market close »

Notable companies…

BBBY

Bed Bath & Beyond

$33.66

-0.48 (-1.41%)

INO

Inovio

$8.06

0.09 (1.13%)

SONC

Sonic

$27.52

-0.51 (-1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.